Synovics Pharmaceuticals, Inc. Share Price

Stocks

SYVC

US87163M1018

Pharmaceuticals

OTC Markets Traded
Market Closed - 07:01:20 09/06/2026 pm IST 5-day change 1st Jan Change
0.000100 USD +9,900.00% Intraday chart for Synovics Pharmaceuticals, Inc. -.--% -
3 months+9,900.00%

Valuation : Synovics Pharmaceuticals, Inc.

Market Cap 16.41L 14.14L 13.25L 12.1L 22.79L 16Cr 22.87L 1.57Cr 61.35L 7.91Cr 61.59L 60.25L 26Cr P/E 2007
-0.73x
P/E 2008 -2.06x
Enterprise Value 81.29L 70.05L 65.68L 59.95L 1.13Cr 78Cr 1.13Cr 7.79Cr 3.04Cr 39Cr 3.05Cr 2.99Cr 130.04Cr EV / Sales 2007
1.81x
EV / Sales 2008 0.6x
Free-Float
95.75%
Yield 2007 *
-
Yield 2008 -
1 day+9,900.00%
3 months+9,900.00%
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0
5 years 0
Extreme 1.0E-6
0
10 years 0
Extreme 1.0E-6
0
Change 5-day change 1-year change 3-year change Capi.($)
+9,900.00%-.--%-.--%-.--% 3.65T
-0.13%-6.44%+60.47%+112.05% 1,04700Cr
+0.85%-0.81%+52.77%+63.15% 65TCr
-1.03%-3.58%+22.87%+73.29% 45TCr
-1.46%-4.50%+37.43%+38.41% 35TCr
-0.72%-2.89%+21.86%+36.79% 29TCr
-1.19%-2.21%+1.35%+12.29% 25TCr
-1.05%-1.57%+51.40%+68.55% 23TCr
+0.08%-1.78%-17.64%-54.29% 20TCr
-2.14%-0.30%+29.42%+89.10% 18TCr
Average +989.31%-2.41%+26.00%+43.93% 36.59TCr
Weighted average by Cap. -0.48%-3.46%+38.66%+65.51%

Financials

2007 2008
Net sales 2.35Cr 2.02Cr 1.9Cr 1.73Cr 3.26Cr 224.28Cr 3.27Cr 22Cr 8.78Cr 113.21Cr 8.81Cr 8.62Cr 375.4Cr 2.6Cr 2.24Cr 2.1Cr 1.91Cr 3.61Cr 248.11Cr 3.62Cr 25Cr 9.71Cr 125.24Cr 9.75Cr 9.53Cr 415.28Cr
Net income -2.09Cr -1.8Cr -1.69Cr -1.54Cr -2.9Cr -199.35Cr -2.91Cr -20Cr -7.8Cr -100.63Cr -7.83Cr -7.66Cr -333.67Cr -40.06L -34.52L -32.36L -29.54L -55.66L -38Cr -55.83L -3.84Cr -1.5Cr -19Cr -1.5Cr -1.47Cr -64Cr
Net Debt 1.88Cr 1.62Cr 1.52Cr 1.39Cr 2.61Cr 179.58Cr 2.62Cr 18Cr 7.03Cr 91Cr 7.05Cr 6.9Cr 300.59Cr 64.88L 55.91L 52.42L 47.85L 90.15L 62Cr 90.43L 6.22Cr 2.43Cr 31Cr 2.44Cr 2.38Cr 103.8Cr
Logo Synovics Pharmaceuticals, Inc.
Synovics Pharmaceuticals, Inc. (Synovics) is a specialty pharmaceutical company engaged in the development, manufacturing and commercialization of generic over the counter (OTC) pharmaceutical products and generic prescription drug products. The Company is a manufacturer, packager and distributor of private label, or store brand, OTC products to chain drug stores, wholesalers and distributors throughout the United States. The Company’s OTC product categories include analgesics, cough and cold, antihistamines, asthma relief and laxatives. The Company has two primary subsidiaries, Kirk Pharmaceuticals, LLC (Kirk), and ANDAPharm, LLC (ANDAPharm). Kirk manufactures and distributes OTC products developed by or licensed to the Company. ANDAPharm serves as the product research and RX manufacturing arm of the Company with a focus on the development of active compounds for drugs.
Employees
155
  1. Stock Market
  2. Stocks
  3. SYVC Stock